The American Journal of Surgery
Volume 199, Issue 1, Supplement , Pages S3-S10 , January 2010

Risk assessment as a guide for the prevention of the many faces of venous thromboembolism

  • Joseph A. Caprini, M.D.

      Affiliations

    • Corresponding Author InformationCorresponding author: Tel.: +1-847-663-8050; fax: +1-847-663-8054

Received 23 July 2009 ,Revised 1 October 2009

References 

  1. Heit JA, Cohen AT, Anderson FA, et al. Estimated annual number of incident and recurrent, non-fatal and fatal venous thromboembolism (VTE) events in the US (abstr). Blood. 2005;10:910
  2. Agnelli G. Prevention of venous thromboembolism in surgical patients. Circulation. 2004;110(Suppl 1):IV4–IV12
  3. Zhan C, Miller MR. Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. JAMA. 2003;290:1868–1874
  4. Spyropoulos AC, Hussein M, Lin J, et al. Rates of symptomatic venous thromboembolism in US surgical patients: a retrospective administrative database study. J Thromb Thrombolysis. 2009;28:458–464
  5. Wakefield TW, Caprini J, Comerota AJ. Thromboembolic diseases. Curr Probl Surg. 2008;45:844–899
  6. Goldhaber SZ. Pulmonary embolism. N Engl J Med. 1998;339:93–104
  7. Pengo V, Lensing AWA, Prins MH, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004;350:2257–2264
  8. Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996;125:1–7
  9. Pesavento R, Bernardi E, Concolato A, et al. Postthrombotic syndrome. Semin Thromb Hemost. 2006;32:744–751
  10. Kahn SR. The post-thrombotic syndrome: the forgotten morbidity of deep venous thrombosis. J Thromb Thrombolysis. 2006;21:41–48
  11. Kahn SR, Hirsch A, Shrier I. Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis. Arch Intern Med. 2002;162:1144–1148
  12. Prandoni P, Lensing AWA, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996;125:1–7
  13. Heit JA. Venous stasis syndrome: the long-term burden of deep vein thrombosis. Hosp Med. 2003;64:593–598
  14. Bernardi E, Bagatella P, Frulla M, et al. Postthrombotic syndrome: incidence, prevention, and management. Semin Vasc Med. 2001;1:71–80
  15. Kahn SR. The Thrombosis Group of Canada guideline on the post-thrombotic syndrome. http://www.tigc.org/pdf/post-thromboticSyndrome.pdf2008;Accessed: June 24, 2009
  16. Anderson FA, Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003;107:I9–I16
  17. Coleridge-Smith PD, Hasty JH, Scurr JH. Venous stasis and vein lumen changes during surgery. Br J Surg. 1990;77:1055–1059
  18. Coleridge Smith PD, Hasty JH, Scurr JH. Deep vein thrombosis: effect of graduated compression stockings on distension of the deep veins of the calf. Br J Surg. 1991;78:724–726
  19. Comerota AJ, Stewart GJ, Alburger PD, et al. Operative venodilation: a previously unsuspected factor in the cause of postoperative deep vein thrombosis. Surgery. 1989;106:301–309
  20. Comerota AJ, Stewart GJ, White JV. Combined dihydroergotamine and heparin prophylaxis of postoperative deep vein thrombosis: proposed mechanism of action. Am J Surg. 1985;150:39–44
  21. Stamatakis JD, Kakkar VV, Sagar S, et al. Femoral vein thrombosis and total hip replacement. BMJ. 1977;2:223–225
  22. Mammen EF. Pathogenesis of venous thrombosis. Chest. 1992;102:640S–644S
  23. Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol. 2004;24:1015–1022
  24. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2008;133:381S–453S
  25. Thromboembolic Risk Factors (THRIFT) Consensus Group. Risk of and prophylaxis for venous thromboembolism in hospital patients. BMJ. 1992;305:567–574
  26. Wheeler HB. Diagnosis of deep vein thrombosis (Review of clinical evaluation and impedance plethysmography). Am J Surg. 1985;150:7–13
  27. Nguyen GC, Sam J. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008;103:2272–2280
  28. Kröger K, Weiland D, Ose C, et al. Risk factors for venous thromboembolic events in cancer patients. Ann Oncol. 2006;17:297–303
  29. Kovacevich GJ, Gaich SA, Lavin JP, et al. The prevalence of thromboembolic events among women with extended bed rest prescribed as part of the treatment for premature labor or preterm premature rupture of membranes. Am J Obstet Gynecol. 2000;182:1089–1092
  30. Anderson FA, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism (The Worcester DVT Study). Arch Intern Med. 1991;151:933–938
  31. Borow M, Goldson H. Postoperative venous thrombosis (Evaluation of five methods of treatment). Am J Surg. 1981;141:245–251
  32. Borow M, Goldson HJ. Prevention of postoperative deep venous thrombosis and pulmonary emboli with combined modalities. Am Surg. 1983;49:599–605
  33. Sugerman HJ, Sugerman EL, Wolfe L, et al. Risks and benefits of gastric bypass in morbidly obese patients with severe venous stasis disease. Ann Surg. 2001;234:41–46
  34. Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest. 2001;119:132S–175S
  35. Caprini JA. Thrombosis risk assessment as a guide to quality patient care. Dis Mon. 2005;51:70–78
  36. Haas S, Wolf H, Kakkar AK, et al. Prevention of fatal pulmonary embolism and mortality in surgical patients: a randomized double-blind comparison of LMWH with unfractionated heparin. Thromb Haemost. 2005;94:814–819
  37. Kucher N, Koo S, Quiroz R, et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med. 2005;352:969–977
  38. O'Shaughnessy D, Rose P, Pressley F, et al. Evaluating the performance of a previously reported risk score to predict venous thromboembolism: a VERITY registry study (abstr). Blood. 2006;108:716
  39. Caprini JA. Why thromboprophylaxis fails. Vasc Dis Manage. 2009;6:47–51
  40. Bahl V, Hu HM, Henke PK, et al. A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg. 2009;Epub September 22, 2009
  41. Zakai NA, Wright J, Cushman M. Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score. J Thromb Haemost. 2004;2:2156–2161
  42. Arcelus JI, Candocia S, Traverso CI, et al. Venous thromboembolism prophylaxis and risk assessment in medical patients. Semin Thromb Hemost. 1991;17(Suppl 3):313–318
  43. Caprini JA, Arcelus JI, Reyna JJ. Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease. Semin Hematol. 2001;38:12–19
  44. Lutz L, Haas S, Hach-Wunderle V, et al. Venöse thromboembolie in der inneren medizin: risikoeinschätzung und medikamentöse prophylaxe. Med Welt. 2002;53:231–234
  45. Osborne NH, Wakefield TW, Henke PK. Venous thromboembolism in cancer patients undergoing major surgery. Ann Surg Oncol. 2008;15:3567–3578
  46. Bergqvist D, Caprini JA, Dotsenko O, et al. Venous thromboembolism and cancer. Curr Probl Surg. 2007;44:157–216
  47. Deheinzelin D, Braga AL, Martins LC, et al. Incorrect use of thromboprophylaxis for venous thromboembolism in medical and surgical patients: results of a multicentric, observational and cross-sectional study in Brazil. J Thromb Haemost. 2006;4:1266–1270
  48. Nicolaides AN, Breddin HK, Fareed J, et al. Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence. Int Angiol. 2001;20:1–37
  49. Davison SP, Venturi ML, Attinger CE, et al. Prevention of venous thromboembolism in the plastic surgery patient. Plast Reconstr Surg. 2004;114:43E–51E
  50. Hatef DA, Kenkel JM, Nguyen MQ, et al. Thromboembolic risk assessment and the efficacy of enoxaparin prophylaxis in excisional body contouring surgery. Plast Reconstr Surg. 2008;122:269–279

 Dr. Caprini is on the speakers' bureau for Covidien and sanofi-aventis; on the advisory board for ConvaTec, Covidien, Eisai, and sanofi-aventis; and a consultant for ConvaTec, Covidien, and sanofi-aventis.

PII: S0002-9610(09)00638-2

doi: 10.1016/j.amjsurg.2009.10.006

The American Journal of Surgery
Volume 199, Issue 1, Supplement , Pages S3-S10 , January 2010

Article Tools

* Image Usage & Resolution